Abstract
1. This paper describes the pharmacological profile of ICI207968, a novel, orally-active and selective inhibitor of 5-lipoxygenase. 2. Inhibition of leukotriene B4 (LTB4) synthesis by 2-substituted indazolinones was not directly related to redox potential but was critically dependent on the nature of the N2 substituent. 2-(3-Pyridylmethyl)-indazolinone (ICI207968) combined selectivity and oral potency. 3. In several in vitro systems ICI207968 exhibited similar lipoxygenase inhibitory potency (IC50 values from 1.5 microM to 6.0 microM) and was approximately 300 times less potent against cyclo-oxygenase, as measured by inhibition of prostaglandin E2 (PGE2) synthesis. 4. ICI207968 also produced selective lipoxygenase inhibition following oral administration in the rat. ED50 values of 2.5, 10 and 25 mg kg-1 p.o. for inhibition of LTB4 release from A23187-stimulated blood were obtained 1, 3 and 5 h after dosing. The compound did not inhibit PGE2 synthesis at oral doses up to 300 mg kg-1. 5. Co-administration of ICI207968 with arachidonic acid, into rabbit dermis, potently inhibited both plasma extravasation and polymorphonuclear leucocyte (PMNL) infiltration induced by this inflammatory fatty acid. The anti-inflammatory potency of a...Continue Reading
References
Jun 15, 1979·Biochemical Pharmacology·G A HiggsJ R Vane
Sep 25, 1989·Biochimica Et Biophysica Acta·R M McMillanV N Jacobs
Oct 15, 1987·Biochemical Pharmacology·D E GriswoldN Hanna
Nov 1, 1987·British Journal of Pharmacology·D M Aked, S J Foster
Jun 1, 1988·British Journal of Pharmacology·J E TatesonL G Garland
Jun 1, 1988·Agents and Actions·R M McMillan, S J Foster
Aug 1, 1988·British Journal of Pharmacology·M Rampart, T J Williams
May 15, 1986·Biochemical Pharmacology·S J FosterD Aked
Apr 1, 1986·Prostaglandins, Leukotrienes, and Medicine·F Carey, R A Forder
Oct 1, 1986·Agents and Actions·M A Bray
Oct 1, 1986·British Journal of Pharmacology·D AkedH C Potts
Feb 1, 1987·Agents and Actions·M J DiMartinoN Hanna
Aug 1, 1981·Prostaglandins·M A BrayM J Smith
Feb 1, 1983·The Journal of Investigative Dermatology·N A SoterK F Austen
May 6, 1983·Science·B Samuelsson
Feb 1, 1983·Prostaglandins·T E RollinsJ Rokach
Nov 1, 1983·British Journal of Pharmacology·R D CampM J Walport
Feb 15, 1984·Biochemical Pharmacology·M K Bach
Apr 1, 1981·Prostaglandins·A UenoY Arai
Sep 1, 1980·Archives of Biochemistry and Biophysics·H H TaiN Lee
Citations
Aug 2, 2000·Pediatric Pulmonology·H Bisgaard
Mar 1, 1991·Agents and Actions·M L Ferrándiz, S J Foster
Mar 1, 1994·Agents and Actions·J A SummersC Robinson
Sep 1, 1991·Agents and Actions·R M McMillanS J Foster
Sep 1, 1991·Agents and Actions·K E Proudman, R M McMillan
Nov 1, 1994·Neuropharmacology·B P ConnopR J Beninger
Aug 1, 1992·Trends in Pharmacological Sciences·R M McMillan, E R Walker
May 12, 1997·European Journal of Pharmacology·G BrunnK Racké
May 30, 1998·Il Farmaco·E A AbordoS L Powell
Nov 1, 1990·British Journal of Pharmacology·R M McMillanS J Foster
Dec 1, 1992·British Journal of Pharmacology·R M McMillanS J Foster
Sep 1, 1993·British Journal of Pharmacology·P K MooreR C Babbedge
Sep 1, 1993·British Journal of Pharmacology·E R PettipherH J Showell
Oct 1, 1993·British Journal of Pharmacology·R A ArmstrongP Lumley
Oct 1, 1993·British Journal of Pharmacology·R A ArmstrongP Lumley
Oct 23, 2012·Journal of Neuroimmunology·Jiaxiang ShaoWeiliang Xia
Jul 28, 2016·Seminars in Cell & Developmental Biology·Weiliang Xia, Keyi Geng
Aug 5, 2005·Chemical & Pharmaceutical Bulletin·Takashi ManoTetsuya Tamura
Mar 1, 1992·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·M A Giembycz, G Dent
Jun 7, 2013·Angewandte Chemie·Isabelle ThoméCarsten Bolm
Oct 17, 1998·La Revue de médecine interne·M C SantaisF Ruff
Jan 5, 1999·Bioorganic & Medicinal Chemistry Letters·B CharpiotT Mueller
Jan 23, 2004·Journal of Medicinal Chemistry·Takashi ManoRodney W Stevens